Voxel S.A. (WSE:VOX)
Poland
· Delayed Price · Currency is PLN 133.20
0.00 (0.00%)
At close: Dec 5, 2025
Voxel Revenue
Voxel had revenue of 142.97M PLN in the quarter ending September 30, 2025, with 6.28% growth. This brings the company's revenue in the last twelve months to 568.83M, up 15.52% year-over-year. In the year 2024, Voxel had annual revenue of 507.77M with 19.71% growth.
Revenue (ttm)
568.83M
Revenue Growth
+15.52%
P/S Ratio
2.46
Revenue / Employee
1.76M
Employees
323
Market Cap
1.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 507.77M | 83.59M | 19.71% |
| Dec 31, 2023 | 424.18M | 63.55M | 17.62% |
| Dec 31, 2022 | 360.64M | -82.02M | -18.53% |
| Dec 31, 2021 | 442.66M | 115.02M | 35.11% |
| Dec 31, 2020 | 327.64M | 115.98M | 54.80% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |
| Scope Fluidics | 718.00K |